The FDA’s move to make transfats harder to use has broad implications for consumers, businesses and the power of government to deny people meaningful choices. Walter Olson explains.
Your favorite podcast, in your inbox.
Sign up for the Cato Daily Podcast Newsletter for exclusive bonus content and highlighted podcast episodes selected by host Caleb O. Brown.